Abstract
The new type of four-component tandem Knoevenagel–Michael reaction was found: assembling arylaldehydes, N,N′-dimethylbarbituric acid, 4-hydroxycoumarine, and morpholine or piperidine has been successfully carried out in alcohols, other organic solvents and water at ambient temperature without catalyst or any other additives and resulted in the selective formation of the new substituted unsymmetrical scaffold with three different heterocyclic rings in 75–98% yields. The crystal structure of morpholin-4-ium 5-[(4-hydroxy-2-oxo-2H-chromen-3-yl)(phenyl)methyl]-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate and morpholin-4-ium 5-[(4-hydroxy-2-oxo-2H-chromen-3-yl)(4-nitrophenyl)methyl]-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate was confirmed by X-ray diffraction study. Thus, this new four-component tandem Knoevenagel–Michael strategy is a selective, facile, and efficient way to unsymmetrical scaffolds with three different pharmacology active heterocyclic rings. The optimized reaction conditions and a mechanistic rationale for this multicomponent assembling are presented.
Graphic abstract
Similar content being viewed by others
References
Tietze LF (1996) Chem Rev 96:115
Zhu J, Bienayme H (eds) (2005) Multicomponent reactions. Wiley-VCH, Weinheim
Zhi S, Ma X, Zhang W (2019) Bioorg Med Chem 17:7632
Jadhav SN, Patil SP, Sahoo DP, Rath D, Parida K, Rode CV (2020) Catal Lett 150:2331
Elinson MN, Ryzhkova YE, Ryzhkov FV (2021) Russ Chem Rev 90:94
Schneider P, Schneider G (2017) Angew Chem Int Ed 56:7971
Yet L (2018) Privileged structures in drug discovery: medicinal chemistry and synthesis. John Wiley and Sons, London
Xu H, Huang R-L, Shu Z, Hong R, Zhang Z (2021) Bioorg Med Chem 19:4978
Brunton LL, Lazo JS, Parker KL, Buxton I, Blumenthal D (2006) Goodman and Gilman’s the pharmacological basis of therapeutics, 11th edn. The McGraw-Hill Companies Inc, New York
Johns MW (1975) Drugs 9:448
Sriram D, Bal TR, Yogeeswari P (2005) J Pharm Pharm Sci 8:565
Lyons KE, Pahwa R (2008) CNS Drugs 22:1037
Uhlmann C, Froscher W (2009) CNS Neurosci Ther 15:24
Grams F, Brandstetter H, D’Alo S, Geppert D, Krell HW, Leinert H, Livi V, Menta E, Oliva A, Zimmermann G (2001) Biol Chem 382:1277
Liu M, Cao D, Russell R, Handschumacher RE, Pizzorno G (1998) Cancer Res 58:5418
Goekjian PG, Jirousek MR (1999) Curr Med Chem 6:877
Gruber P, Rechfeld F, Kirchmair J, Hauser N, Boehler M, Garczarczyk D, Langer T, Hofmann J (2011) J Biochem 149:331
Brahmachari G, Mandal M, Karmakar I, Nurjamal K, Mandal B (2019) ACS Sustain Chem Eng 7:6369
Pingaew R, Saekee A, Mandi P, Nantasenamat C, Prachayasittikul S, Ruchirawat S, Prachayasittiku V (2014) Eur J Med Chem 85:65
Hildebrandt EF, Suttie JW (1982) Biochemistry 21:2406
Kayser O, Kolodziej H (1997) Planta Med 63:508
Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN (2004) Curr Pharm Des 10:3813
Huang XY, Shan ZJ, Zhai HL, Su L, Zhang XY (2011) Chem Biol Drug Des 78:651
Kontogiorgis CA, Hadjipavlou-Litina DJJ (2005) Med Chem 48:6400
Sashidhara KV, Kumar A, Kumar M, Srivastava A, Puri A (2010) Bioorg Med Chem Lett 20:6504
Kurt BZ, Gazioglu I, Sonmez F, Kucukislamoglu M (2015) Bioorg Chem 59:80
Barros TAA, Freitas LAR, Filho JMB, Nunes XP, Giulietti AM, Souza GE, Santo RR, Soares MB, Villarreal CFJ (2010) Pharm Pharmacol 62:205
Sashidhara KV, Kumar A, Chatterjee M, Rao KB, Singh S, Verma AK, Palit G (2011) Bioorg Med Chem Lett 21:1937
Luchini AC, Rodrigues-Orsi P, Cestari SH, Seito LN, Witaicenis A, Pellizzon CH, Stasi LCD (2008) Biol Pharm Bull 31:1343
Velasco-Velázquez MA, Agramonte-Hevia J, Barrera D, Jiménez-Orozco A, García-Mondragón MJ, Mendoza-Patiño N, Landa A, Mandoki J (2003) Cancer Lett 198:179
Kirkiacharian BS, Clercq E, Kurkjian R, Pannecouque CJ (2008) Pharm Chem 42:265
Kumari A, Singh RK (2020) Biorg Chem 96:103578
Kourounakis AP, Xanthopoulos D, Tzara A (2020) Med Res Rev 40:709
Cotten JF, Keshavaprasad B, Laster MJ, Eger EI, Yost CS (2006) Anesth Analg 102:779
Stoops WW, Strickland JC, Alcorn JL, Hays LR, Rayapati AO, Lile JA, Rush CR (2019) Psychopharmacology 236:2569
Bonnet U (2003) CNS Drug Rev 9:97
Naidu C, Kulkarni J (2019) Aust N Z J Psychiatry 53:1227
Walsh SL, Heilig M, Nuzzo PA, Henderson P, Lofwall MR (2013) Addict Biol 18:332
Patel MSN, Ahmed MH, Saqib M, Shaikh SN (2019) J Drug Deliv Ther 9:542
Pesyan NN, Rashidnejad H, Esmaeili MA, Safari E, Tunç T, Alilou M, Safavi-Sohi R, Şahin E (2020) J Chin Chem Soc 67:1679
Katsamakas S, Papadopoulos AG, Kouskoura MG, Markopoulou CK, Hadjipavlou-Litina D (2019) Future Med Chem 11:2063
Barakat A, Ali M, Al Majid AM, Yousuf S, Choudhary MI (2016) Diethylammonium salts of phenyl-substituted thiobarbituric acid as anti-diabetic agents. US Patent 9527820, Dec 27, 2016; Chem Abstr 166:112656
Barakat A, Al-Majid AM, Al-Najjar HJ, Mabkhot YN, Javaid S, Yousuf S, Choudhary MI (2014) Eur J Med Chem 84:146
Wender PA (2014) Nat Prod Rep 31:433
Zhang W, Yi W-B (2019) Pot, atom and step economy (PASE) synthesis. Springer, Berlin
Elinson MN, Vereshchagin AN, Anisina YE, Egorov MP (2020) Polycycl Aromat Compd 40:108
Elinson MN, Nasybullin RF, Ryzhkov FV, Egorov MP (2014) C R Chim 17:437
Vereshchagin AN, Elinson MN, Dorofeeva EO, Stepanov NO, Zaimovskaya TA, Nikishin GI (2013) Tetrahedron 64:9766
Elinson MN, Medvedev MG, Ilovaisky AI, Merkulova VM, Zaimovskaya TA, Nikishin GI (2013) Mendeleev Commun 23:94
Vereshchagin AN, Elinson MN, Zaimovskaya TA, Nikishin GI (2008) Tetrahedron 69:1945
Irani S, Maghsoodlou MT, Hazeri N (2017) J Iran Chem Soc 14:1189
Elinson MN, Vereshchagin AN, Feducovich SK, Zaimovskaya TA, Starikova ZA, Belyakov PA, Nikishin GI (2007) Tetrahedron Lett 48:6614
Elinson MN, Vereshchagin AN, Stepanov NO, Belyakov PA, Nikishin GI (2010) Tetrahedron Lett 51:6998
Vereshchagin AN, Elinson MN, Nasybullin RF, Bobrovsky SI, Bushmarinov IS, Egorov MP (2015) Helv Chim Acta 98:1104
Gaich T, Baran PS (2010) J Org Chem 75:4657
Acknowledgements
Crystal structure determination for compound 2a was performed in the Department of Structural Studies of Zelinsky Institute of Organic Chemistry, Moscow. Crystal structure determination for compounds 2h and 4e were performed with the financial support from Ministry of Science and Higher Education of the Russian Federation using the equipment of Center for molecular composition studies of INEOS RAS and are also gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Elinson, M.N., Vereshchagin, A.N., Ryzhkova, Y.E. et al. Direct four-component assembling of arylaldehydes, dimethylbarbituric acid, 4-hydroxycoumarine, and cyclic amines into complex scaffolds with three different heterocyclic rings. Monatsh Chem 152, 1327–1336 (2021). https://doi.org/10.1007/s00706-021-02849-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-021-02849-w